Literature DB >> 26592445

Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.

X Chen1, S A Kamranvar1, M G Masucci1.   

Abstract

Infection of human B lymphocytes by Epstein-Barr virus (EBV) leads to the establishment of immortalized lymphoblastoid cell lines (LCLs) that are widely used as a model of viral oncogenesis. An early consequence of infection is the induction of DNA damage and activation of the DNA damage response, which limits the efficiency of growth transformation. The cause of the DNA damage remains poorly understood. We have addressed this question by comparing the response of B lymphocytes infected with EBV or stimulated with a potent B-cell mitogen. We found that although the two stimuli induce comparable proliferation during the first 10 days of culture, the EBV-infected blasts showed significantly higher levels of DNA damage, which correlated with stronger and sustained accumulation of reactive oxygen species (ROS). Treatment with ROS scavengers decreased DNA damage in both mitogen-stimulated and EBV-infected cells. However, while mitogen-induced proliferation was slightly improved, the proliferation of EBV-infected cells and the establishment of LCLs were severely impaired. Quenching of ROS did not affect the kinetics and magnitude of viral gene expression but was associated with selective downregulation of the viral LMP1 and phosphorylated cellular transcription factor STAT3 that have key roles in transformation. Analysis of the mechanism by which high levels of ROS support LMP1 expression revealed selective inhibition of viral microRNAs that target the LMP1 transcript. Our study provides novel insights into the role of EBV-induced oxidative stress in promoting B-cell immortalization and malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26592445     DOI: 10.1038/onc.2015.450

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  60 in total

1.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

2.  B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation.

Authors:  Siva Koganti; Amanda de la Paz; Alexandra F Freeman; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.

Authors:  G Miller; T Shope; H Lisco; D Stitt; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

4.  Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker.

Authors:  Takao Kinjo; Julia Ham-Terhune; Jean-Marie Peloponese; Kuan-Teh Jeang
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

Review 5.  Oxidative stress during viral infection: a review.

Authors:  K B Schwarz
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes.

Authors:  Ramakrishna Sompallae; Simone Callegari; Siamak Akbari Kamranvar; Maria G Masucci
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

7.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.

Authors:  B Gruhne; R Sompallae; M G Masucci
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

9.  Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases.

Authors:  Tianshuang Liu; Shawn Castro; Allan R Brasier; Mohammad Jamaluddin; Roberto P Garofalo; Antonella Casola
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

10.  Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2.

Authors:  Daniel Portal; Hufeng Zhou; Bo Zhao; Peter V Kharchenko; Elizabeth Lowry; Limsoon Wong; John Quackenbush; Dustin Holloway; Sizun Jiang; Yong Lu; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

View more
  20 in total

1.  Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.

Authors:  Xue Lian; Chenyi Bao; Xueqi Li; Xunhai Zhang; Hongjun Chen; Yong-Sam Jung; Yingjuan Qian
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

2.  The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.

Authors:  Ossie F Dyson; Joseph S Pagano; Christopher B Whitehurst
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

Authors:  Hans Knecht; Nathalie A Johnson; Tina Haliotis; Daniel Lichtensztejn; Sabine Mai
Journal:  Lab Invest       Date:  2017-04-24       Impact factor: 5.662

4.  Limited nucleotide pools restrict Epstein-Barr virus-mediated B-cell immortalization.

Authors:  A Y Hafez; J E Messinger; K McFadden; G Fenyofalvi; C N Shepard; G M Lenzi; B Kim; M A Luftig
Journal:  Oncogenesis       Date:  2017-06-12       Impact factor: 7.485

Review 5.  Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.

Authors:  Kwai Fung Hui; Kam Pui Tam; Alan Kwok Shing Chiang
Journal:  Viruses       Date:  2017-11-21       Impact factor: 5.048

Review 6.  DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations.

Authors:  Mankgopo Magdeline Kgatle; Catherine Wendy Spearman; Asgar Ali Kalla; Henry Norman Hairwadzi
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

7.  Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action.

Authors:  Gokul Variar; Tarun Pant; Apoorva Singh; Abinaya Ravichandran; Sushant Swami; Balaraman Kalyanaraman; Anuradha Dhanasekaran
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 8.  Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization.

Authors:  Siamak A Kamranvar; Maria G Masucci
Journal:  Viruses       Date:  2017-08-09       Impact factor: 5.048

Review 9.  A Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -Diseases.

Authors:  Xiaofan Li; Sumita Bhaduri-McIntosh
Journal:  Front Microbiol       Date:  2016-07-08       Impact factor: 5.640

10.  Combination of betulinic acid and chidamide synergistically inhibits Epstein-Barr virus replication through over-generation of reactive oxygen species.

Authors:  Haibing Yu; Hongyu Zhang; Zhigang Chu; Qiongfang Ruan; Xueru Chen; Danli Kong; Xiaodong Huang; Huawen Li; Huanwen Tang; Hongjin Wu; Yifei Wang; Weiguo Xie; Yuanling Ding; Paul Yao
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.